Amalgamated Bank’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Hold |
2,590
| – | – | ﹤0.01% | 2040 |
|
|
2025
Q1 | $22K | Buy |
2,590
+280
| +12% | +$2.38K | ﹤0.01% | 2019 |
|
|
2024
Q4 | $25K | Hold |
2,310
| – | – | ﹤0.01% | 2029 |
|
|
2024
Q3 | $13K | Hold |
2,310
| – | – | ﹤0.01% | 2311 |
|
|
2024
Q2 | $10K | Hold |
2,310
| – | – | ﹤0.01% | 2422 |
|
|
2024
Q1 | $12K | Sell |
2,310
-7,573
| -77% | -$39.3K | ﹤0.01% | 2342 |
|
|
2023
Q4 | $92K | Sell |
9,883
-687
| -6% | -$6.4K | ﹤0.01% | 2023 |
|
|
2023
Q3 | $69K | Hold |
10,570
| – | – | ﹤0.01% | 2120 |
|
|
2023
Q2 | $86K | Buy |
10,570
+1,039
| +11% | +$8.45K | ﹤0.01% | 2117 |
|
|
2023
Q1 | $82K | Sell |
9,531
-1,450
| -13% | -$12.5K | ﹤0.01% | 2125 |
|
|
2022
Q4 | $102K | Hold |
10,981
| – | – | ﹤0.01% | 2126 |
|
|
2022
Q3 | $113K | Buy |
10,981
+277
| +3% | +$2.85K | ﹤0.01% | 2094 |
|
|
2022
Q2 | $107K | Sell |
10,704
-219
| -2% | -$2.19K | ﹤0.01% | 2142 |
|
|
2022
Q1 | $134K | Sell |
10,923
-750
| -6% | -$9.2K | ﹤0.01% | 2090 |
|
|
2021
Q4 | $202K | Buy |
11,673
+238
| +2% | +$4.12K | ﹤0.01% | 1972 |
|
|
2021
Q3 | $205K | Sell |
11,435
-283
| -2% | -$5.07K | ﹤0.01% | 1987 |
|
|
2021
Q2 | $268K | Buy |
+11,718
| New | +$268K | ﹤0.01% | 1932 |
|